/Cooper%20Companies%2C%20Inc_%20sign%20on%20building-by%20Sundry%20Photography%20via%20Shutterstock.jpg)
Valued at a market cap of $16.2 billion, The Cooper Companies, Inc. (COO) is a medical device company focused on improving vision and women’s health. Based in San Ramon, California, the company develops, manufactures, and markets contact lenses, while also offering a broad range of products and services for women’s healthcare, including fertility solutions and cryostorage services. It is scheduled to announce its fiscal Q1 earnings for 2026 in the near future.
Ahead of this event, analysts expect this healthcare company to report a profit of $1.03 per share, up 12% from $0.92 per share in the year-ago quarter. The company has met or surpassed Wall Street’s bottom-line estimates in each of the last four quarters. Its earnings of $1.15 per share in the previous quarter topped the consensus estimates by 3.6%.
